← Leaderboards
Thomas C Dowling
University Of Maryland Baltimore
$288,835
Attributed
$288,835
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $232.9K · FY2005–09$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$288,835 · 9
By mechanism
R15$222,750 · 1
M01$66,085 · 8
Top collaborators
No co-investigators on record.
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- William M Atkins$17,142,346
- Anthony J. Kim$3,391,136
- Huang Chiao Huang$6,185,360
- Natalie D Eddington$3,258,783
- Claudia Rose Baquet$15,865,421
Research focus
Computer Retrieval Of Information On Scientific Projects DatabaseResourcesSourceGeneticGrantResearch PersonnelUnited States National Institutes Of HealthFundingClinical ResearchInstitutionPharmaceutical PreparationsDrug KineticsDrug InteractionsDrug MetabolismRenal FunctionDiabetes MellitusEvaluationPharmacogenomicsHispanic AmericansKidneyDrug TransportGenesHealthy VolunteerKidney Diseases
Grant awards (9)
PHARMACOGENOMIC STUDY IN HISPANIC AMERICANS WITH DIABETES$7,003
M01 · FY2009 · RR · contact PI
EVALUATION OF RENAL DRUG TRANSPORT IN HEALTHY VOLUNTEERS$3,500
M01 · FY2009 · RR · contact PI
EVALUATION OF RENAL DRUG TRANSPORT IN HEALTHY VOLUNTEERS$16,113
M01 · FY2008 · RR · contact PI
PHARMACOGENOMIC STUDY IN HISPANIC AMERICANS WITH DIABETES$1,052
M01 · FY2007 · RR · contact PI
ENOS RENAL FUNCTION STUDY$13,369
M01 · FY2006 · RR · contact PI
PHARMACOGENOMIC STUDY IN HISPANIC AMERICANS WITH DIABETES$495
M01 · FY2006 · RR · contact PI
IVIVC MODEL FOR RENAL DRUG CLEARANCE$222,750
R15 · FY2005 · GM
ENOS GENOTYPE$10,157
M01 · FY2005 · RR
Bioavailability of a 20% topical ketoprofen formulation$14,396
M01 · FY2004 · RR